BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 12192269)

  • 1. Present standards for cervical cancer screening.
    O'Meara AT
    Curr Opin Oncol; 2002 Sep; 14(5):505-11. PubMed ID: 12192269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New tests for cervical cancer screening.
    Nuovo J; Melnikow J; Howell LP
    Am Fam Physician; 2001 Sep; 64(5):780-6. PubMed ID: 11563569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of human papillomavirus in screening for cervical cancer.
    McFadden SE; Schumann L
    J Am Acad Nurse Pract; 2001 Mar; 13(3):116-25; quiz 127-8. PubMed ID: 11930583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
    Melinte-Popescu A; Costăchescu G
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer and women with HIV.
    Denenberg R
    GMHC Treat Issues; 1997; 11(7-8):10-8. PubMed ID: 11364643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
    Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
    J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer screening. Who needs a Pap test? How often?
    Benedet JL; Murphy KJ
    Postgrad Med; 1985 Dec; 78(8):69-71, 74-6, 78-9. PubMed ID: 4070103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards improving cervical cancer screening in Nigeria: a review of the basics of cervical neoplasm and cytology.
    Dim CC
    Niger J Clin Pract; 2012; 15(3):247-52. PubMed ID: 22960955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for cancer of the cervix with simultaneous pap smear and colposcopy. The efficacy of pap smear and colposcopy.
    Kuramoto H; Sugimoto N; Iida M
    Eur J Gynaecol Oncol; 2011; 32(1):73-6. PubMed ID: 21446330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
    Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on cervical cancer screening. Current diagnostic and evidence-based management protocols.
    Ball C; Madden JE
    Postgrad Med; 2003 Feb; 113(2):59-64, 70. PubMed ID: 12611115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
    Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
    Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of simultaneous cervical cytology, HPV testing, and colposcopy.
    Hockstad RL
    Fam Pract Res J; 1992 Mar; 12(1):53-60. PubMed ID: 1312758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of abnormal pap smear--consensus guidelines of the National Cervical Cancer Screening Programme in Poland Coordinating Centre, the Polish Gynaecological Society, the Polish Society of Pathologists, and Polish Society of Colposcopy and Uterine Cervix Pathology.
    ; ; ;
    Ginekol Pol; 2009 Feb; 80(2):129-38. PubMed ID: 19338211
    [No Abstract]   [Full Text] [Related]  

  • 16. Cervical cancer: developments in screening and evaluation of the abnormal Pap smear.
    Walsh JM
    West J Med; 1998 Nov; 169(5):304-10. PubMed ID: 9830367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of PAPNET: review of 25,656 Pap smears negative on manual screening and rapid rescreening.
    Halford JA; Wright RG; Ditchmen EJ
    Cytopathology; 1999 Oct; 10(5):317-23. PubMed ID: 10588350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening. Past success and future challenge.
    Dewar MA; Hall K; Perchalski J
    Prim Care; 1992 Sep; 19(3):589-606. PubMed ID: 1410065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
    Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant reduction in the rate of false-negative cervical smears with neural network-based technology (PAPNET Testing System).
    Koss LG; Sherman ME; Cohen MB; Anes AR; Darragh TM; Lemos LB; McClellan BJ; Rosenthal DL; Keyhani-Rofagha S; Schreiber K; Valente PT
    Hum Pathol; 1997 Oct; 28(10):1196-203. PubMed ID: 9343327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.